John Cox's Net Worth
$32.7 Million
Who is John Cox?
John Cox has an estimated net worth of $32.7 Million. This is based on reported shares across multiple companies, which include BIOGEN INC., REPLIGEN CORP, Sigilon Therapeutics, Inc., and Bioverativ Inc..
SEC CIK
John Cox's CIK is 0001498428
Past Insider Trading and Trends
2011 was John Cox's most active year for acquiring shares with 11 total transactions. John Cox's most active month to acquire stocks was the month of January. 2011 was John Cox's most active year for disposing of shares, totalling 26 transactions. John Cox's most active month to dispose stocks was the month of January. 2011 saw John Cox paying a total of $2,985,310.62 for 73,403 shares, this is the most they've acquired in one year. In 2015 John Cox cashed out on 35,990 shares for a total of $7,578,695.11, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BIOGEN INC. (BIIB) Snapshot price: $241.335
EVP Pharmaceutical Oper & Tech
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +27.59% | 8.44K |
—
|
—
| 39.05K |
Apr 1
| |||
Form 4
| +1.42% | 428 |
$258.99 | -$98,934.18 | 30.52K |
Feb 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 22
| |||
Form 4
| +6.16% | 1.75K |
$247.22 | -$383,685.44 | 30.09K |
Feb 12
| |||
Form 4
| +10.54% | 2.7K |
$250.77 | -$332,019.48 | 28.34K |
Feb 8
| |||
Form 4
| -21.36% | -6.94K |
$257.46 | -$5,059,639.39 | 25.57K |
Scheduled
|
Mar 25
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 4
| +6.47% | 1.98K |
$392.11 | -$690,505.71 | 32.51K |
Feb 12
| |||
Form 4
| +19.43% | 4.97K |
$398.98 | -$1,494,978.80 | 30.53K |
Feb 8 - Feb 9
| |||
Form 4
| +5.68% | 1.37K |
$347.11 | -$426,251.08 | 25.48K |
Feb 23
| |||
Form 4
| +5.18% | 1.19K |
$323.04 | -$342,099.36 | 24.11K |
Feb 12
| |||
Form 4
| +28.34% | 5.06K |
$315.54 | -$1,152,667.62 | 22.92K |
Feb 8 - Feb 9
| |||
Form 4
| -1.11% | -200.00 |
—
|
—
| 17.86K |
Nov 25
| |||
Form 4
| -4.58% | -866.00 |
$218.85 | -$189,524.10 | 18.06K |
May 3
| |||
Form 4
| +7.88% | 1.37K |
$164.40 | -$201,718.80 | 18.76K |
Feb 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 4
| +42.78% | 5.21K |
$164.44 | -$488,222.36 | 17.39K |
Feb 8 - Feb 9
| |||
Form 4
| -5.91% | -765.00 |
$134.26 | -$102,708.90 | 12.18K |
May 3
| |||
Form 4
| -0.49% | -63.00 |
$116.52 | -$310,282.92 | 12.71K |
Feb 23 - Feb 24
| |||
Form 4
| +33.25% | 3.19K |
$117.78 | -$177,141.12 | 12.78K |
Feb 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 4
|
—
|
0
|
$93.62 | -$90,262.50 | 9.59K |
Scheduled
|
Nov 1
| ||
Form 4
| -7.39% | -765.00 |
$97.99 | -$74,962.35 | 9.59K |
May 3
| |||
Form 4
|
—
|
0
|
$86.44 | -$118,015.50 | 10.35K |
Scheduled
|
Apr 21
| ||
Form 4
|
—
|
0
|
$68.36 | -$843,074.13 | 10.35K |
Scheduled
|
Apr 13
| ||
Form 4
|
—
|
0
|
$62.96 | -$207,552.00 | 10.35K |
Scheduled
|
Apr 11
| ||
Form 4
|
—
|
0
|
$58.25 | -$83,780.00 | 9.82K |
Scheduled
|
Mar 31
| ||
Form 4
| -29.16% | -4.04K |
$70.10 | -$283,258.61 | 9.82K |
Mar 2
| |||
Form 4
| -7.98% | -1.20K |
$67.26 | -$80,846.52 | 13.86K |
Feb 24
| |||
Form 4
| +10.72% | 1.46K |
$66.76 | -$45,396.80 | 15.06K |
Feb 23
| |||
Form 4
| -11.93% | -1.84K |
$67.08 | -$123,619.59 | 13.6K |
Scheduled
|
Feb 17
| ||
Form 4
| -5.56% | -910.00 |
$65.83 | -$59,905.30 | 15.45K |
Feb 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9
| |||
Form 4
| -4.51% | -773.00 |
$62.87 | -$48,596.96 | 16.36K |
Scheduled
|
Nov 9
| ||
Form 4
| -6.16% | -1.13K |
$62.88 | -$70,745.59 | 17.13K |
Scheduled
|
Nov 1 - Nov 2
| ||
Form 4
|
—
|
0
|
$48.49 | -$200,307.00 | 18.25K |
Scheduled
|
Oct 28
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
REPLIGEN CORP (RGEN) Snapshot price: $201.705
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -66.81% | -1.86K |
$96.72 | -$179,705.76 | 923 |
Mar 24
| |||
Form 4
|
—
|
0
|
$59.82 | -$1,895,432.04 | 2.78K |
Mar 18
| |||
Form 4
|
—
|
0
|
$53.15 | -$804,800.00 | 2.78K |
Mar 4
| |||
Form 4
| -61.57% | -4.46K |
$92.81 | -$413,454.80 | 2.78K |
Feb 24
| |||
Form 4
| +14.62% | 923 |
—
|
—
| 7.24K |
May 15
| |||
Form 4
| +30.79% | 1.49K |
—
|
—
| 6.31K |
May 16
| |||
Form 4
| +33.31% | 1.21K |
—
|
—
| 4.83K |
May 18
| |||
Form 4
| +94.89% | 1.76K |
—
|
—
| 3.62K |
May 11
| |||
Form 4
|
∞
| 1.86K |
—
|
—
| 1.86K |
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sigilon Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -341.00 |
—
|
—
|
0
|
Aug 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
∞
| 4.44K |
—
|
—
| 4.44K |
Dec 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Bioverativ Inc. No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -185.09K |
—
|
—
|
0
|
Mar 8
| |||
Form 4
| -9.65% | -19.77K |
$104.43 | -$2,064,247.46 | 185.09K |
Feb 22 - Feb 23
| |||
Form 4
| +7.07% | 13.52K |
$103.52 | -$1,119,982.88 | 204.86K |
Feb 14
| |||
Form 4
| +5.93% | 10.71K |
$56.29 | -$615,428.67 | 191.34K |
Feb 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
| -4.45% | -8.42K |
$54.46 | -$458,335.36 | 180.63K |
Mar 31
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
| +1,135.61% | 173.75K |
$46.09 | -$1,748,144.32 | 189.05K |
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Dyne Therapeutics, Inc. (DYN) No price found
CEO & President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||